pulmatrix.com - PULM Company profit before taxes, interest and amortization
Key catalysts for Pulmatrix, Inc. (PULM) include successful trials of inhaled therapies for lung pathologies and M&A prospects. The EBITDA_Co trend clearly demonstrates financial stability, where 0.00 describes the current status of the metric. Pulmatrix, Inc. (PULM) is developing targeted delivery methods for COPD and mycoses. The current strategy is focused on completing clinical trials to facilitate subsequent licensing agreements.
Summary analytical data breakdowns for Pulmatrix (PULM)
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
- earnings and market ratios statistics:
PULM - Net Profit|Projected Future Earnings Pulmatrix, Inc.|PULM - Price to Earnings Ratio|Market Cap to Future Earnings Ratio pulmatrix.com|PULM - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Pulmatrix|PULM - Operating profit EBITDA|Net earnings per share for the last four quarters Pulmatrix|PULM - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last 12 months pulmatrix.com|PULM - Net earnings per share growth this year|Expected earnings per share trend next year Pulmatrix, Inc.
Fundamental company valuation:PULM (Pulmatrix Corporation)
This metric is calculated as the sum of operating profit and depreciation and amortization, excluding the impact of tax burdens and debt obligations to assess the business's net cash flow. The stability of the EBITDA figure confirms the ability of Pulmatrix, Inc. (PULM) to monetize its innovative inhalation developments in pulmonology, demonstrating the company's actual financial resilience to market fluctuations through the lens of factual operating earnings.
Competitors of Pulmatrix, Inc. (PULM)
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Galapagos GLPG|ANIP (ANI Pharmaceuticals Inc) - Profit before deduction of interest, taxes, depreciation and amortization|MNKD: Operating profit before deduction of amortization|AMPH - Operating profit EBITDA|Pacira BioSciences (PCRX) - Profit before payment of interest, taxes and amortization|SPRY (ars-pharma.com) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Theravance Biopharma, Inc.|Operating profit before deduction of amortization Aquestive Therapeutics Inc (AQST)|Operating profit EBITDA SCPH|Operating profit EBITDA tectonictx.com (TECX)|Tonix Pharmaceuticals - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization SXTC (SXT Pharmaceuticals)|EPRX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization BHST (BioHarvest Sciences, Inc.)|EXOZ: Operating profit EBITDA|ORMP - Operating income before deduction of amortization|Operating profit before deduction of amortization ENTX|Operating profit before amortization HYFT (ipatherapeutics.com)|Operating profit before deduction of amortization ABVC (ABVC BioPharma, Inc.)|CPIX (Cumberland Pharmaceuticals Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA QNTM (Quantum BioPharma Limited)|Operating income before deduction of amortization FibroGen Corporation (FGEN)|TELO - Profit before payment of interest, taxes and amortization|RANI (Rani Therapeutics) - Operating profit before amortization|SNYR: Operating profit EBITDA|Operating profit before deduction of amortization Rallybio|Operating profit before deduction of amortization LEXX|Pheton (PTHL) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Aptorum Group Limited (APM)|LYRA: Profit before deduction of interest, taxes, depreciation and amortization|Impact BioMedical - Operating profit before deduction of amortization|Operating profit EBITDA TNF Pharmaceuticals Inc. TNFA|YCBD - Profit before payment of interest, taxes and amortization|PRFX: Profit before payment of interest, taxes and amortization|altamiratherapeutics.com (CYTO) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization lipella.com|Profit before payment of interest, taxes and amortization OptiNose|Pieris Pharmaceuticals Inc - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA PROC|PTPI (Petros Pharma) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA QLI (Qilian International)|Operating profit EBITDA acelyrin.com SLRN|TFFP - Profit before payment of interest, taxes and amortization
